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Abstract
The recent perspective article “How Neoliberalism Is Shaping the Supply of Unhealthy Commodities and 
What This Means for NCD Prevention,” by Lencucha and Throw, interrogates how the dominant neoliberal 
paradigm restricts meaningful policy action to prevent non-communicable diseases (NCDs). It contributes an 
NCD perspective to the existing literature on neoliberalism and health, which to date has been dominated by 
a focus on HIV, gender and trade agreements.  It further advances the emerging commercial determinants of 
health (CDoH) scholarship by calling for more nuanced analysis of how the governance of both health and the 
economy facilitates corporate influence in policy-making. In political science terms, Lencucha and Throw are 
calling for greater structural analysis. However, their focus on the pragmatic, as opposed to political, aspects of 
neoliberalism reflects a hesitancy within health scholarship to engage in political analysis. This depoliticization 
of health serves neoliberal interests by delegitimizing critical questions about who sustains and benefits 
from current institutional norms.  Lencucha and Throw’s call for greater interrogation of the structures of 
neoliberalism forms a basis from which to advance analysis of the political determinants of health.
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Introduction
In 1848, Rudolf Virchow, a cellular pathologist and public 
health pioneer, wrote, “Medicine is a social science, and 
politics nothing but medicine at a larger scale.”1 Despite being 
one of most frequently quoted one-liners in public health, the 
relationship between politics and health remains neglected in 
health scholarship. The perspective article “How Neoliberalism 
Is Shaping the Supply of Unhealthy Commodities and What 
This Means for NCD Prevention” by Lencucha and Throw 
takes a step to rectifying this gap by interrogating how the 
dominant neoliberal paradigm restricts policy action to 
prevent non-communicable diseases (NCDs).2 It contributes 
to literature on neoliberalism and health and the commercial 
determinants of health (CDoH). However, further critical 
analysis is needed to advance understanding of political 
determinants of health, which are the “norms, policies and 
practices that arise from transnational interaction … that 
cause and maintain health inequities.”3
The commentary contributes an NCD perspective to 
the existing literature on neoliberalism and health, which 
to date has been dominated by a focus on HIV, gender and 
trade agreements. The HIV epidemic, in particular, catalyzed 
critical analysis of how neoliberal policies exacerbated health 
inequities. Take Msimang’s description of the links between 
mining development and the spread of the HIV epidemic in 
South Africa: 
“If there was a recipe for creating an AIDS epidemic in 
Southern Africa, it would read as follows: ‘Steal some land 
and subjugate its people. Take some men from rural areas 
and put them in hostels far away from home, in different 
countries if need be. Build excellent roads. Ensure that the 
communities surrounding the men are impoverished so 
that a ring of sex workers develops around each mining 
town. Add HIV.”4 
Also writing from a feminist perspective, but focused on the 
response as opposed to the drivers to HIV, O’Manique argues 
neoliberal assumptions prioritize interventions focused on 
individual behavior change and fail to recognize the unpaid 
care work of women.5 Scholarship on the HIV response 
has also advanced analysis of how free trade agreements, 
informed by neoliberal ideals, influenced who has access to 
life prolonging medications and who does not.6 More recent 
research documents how corporations use trade agreements 
to oppose public health policies, such as the standardized 
packaging of tobacco products, and to facilitate market 
expansion for unhealthy products.7 While political scientists 
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and ethicists have contributed further theoretical insights 
on neoliberalism influences over health and within health 
governance,3 the public health literature remains focuses on 
case studies or select actors. 
There has been an increasing in interest in the CDoH 
- the activities of profit seeking entities that effect health 
outcomes.8 Kickbush et al’s framework identifies drivers (such 
as internationalization of trade and capital), channels (such 
as marketing and lobbying) and outcomes (related to policy 
environment, consumers and health) of CDoH.9 Lencucha 
and Throw’s analysis particularly advances discussion on, and 
stresses the importance of, the global drivers. It illustrates how 
neoliberal norms and institutions influence perceptions of the 
‘proper’ relationship between government and market (small 
government and free markets); the perceived need to ‘balance’ 
economic and health interests (with the scales weighted in 
favour of economic gain); and the ‘right’ of corporations 
to participate in decision-making around health (such as 
product regulation). Notably, it calls for greater research into 
the supply-side of product environments, an aspect neglected 
in the CDoH literature, which is predominantly focused on 
the marketing and lobbying activities of corporations. This is 
an important call for nuanced analysis of how the governance 
of both health and the economy facilitates corporate influence 
in policy-making. 
In political science terms, Lencucha and Throw are arguing 
for a focus on structure, as well as agency. Structure refers to 
the macro forces, such as culture and political ideologies, that 
construct the parameters of choice and action, while agency 
refers to actors’ capacity to act upon a situation as relatively 
autonomous individuals.10 Social scientists have spent much 
energy debating whether structure or agency is the dominant 
force in social and political life. Nuanced analyses note that 
structure and agency are two sides of the same coin, advocating 
for greater interrogation of the relationship between them.11 
Lencucha and Throw point out that the majority of literature 
on NCD prevention and policies has focused on actors, 
neglecting analysis of the structures they operate within. They 
take a step towards rectifying this imbalance by identifying 
neoliberalism as the dominant structural force that limits 
options within NCD health policy-making.
However, their “focus on the paradigmatic (rather than 
political) aspect of neoliberalism” limits analysis of the power 
relationships that create, sustain and benefit from these 
structures.2 Indeed, it is arguable whether the pragmatic 
and political aspects of neoliberalism can be separated.12 
Neoliberalism is “a political project” developed from 
ideologies aimed at reconfiguring state roles, increasing the 
power of private actors and limiting acceptable forms of 
global governance.13 As Gill and Benatar write, “neoliberal 
capitalism is not just a set of economic processes but 
also a system of power. This system does not involve the 
accumulation of goods to improve livelihood and social 
wellbeing, but is driven by the accumulation of monetary 
values (exchange values) for profit.”14 Ignoring this agenda, 
and how it contradicts health equity goals, results in an 
analysis that, while clearly describing neoliberalism’s rise and 
functions, does so as if neoliberal institutions just appeared, 
sustained by some mysterious force. It is like describing the 
workings of a machine, without mentioning its purpose or the 
type of fuel it runs on. 
This approach reflects a hesitancy in global health 
scholarship to engage in critical political analysis. Kay and 
Williams write that literature on global health governance in 
general “has largely failed to ground analysis of global health 
issues and outcomes within the broader political economic 
project of globalization.”15 While, as outlined above, there is 
an increasing body of research on neoliberalism and health, 
much of this comes from feminist and political economy 
scholars. Analysis of the intersections between politics and 
health remains peripheral in global and public health fields. 
For example, the first global health conference focused on 
political economy, the Prince Mahidol Award Conference 
in Thailand, was held in 2019.16 The Lancet-University of 
Oslo Commission Report on Global Governance for Health, 
despite the stated focus on governance (a political process), 
failed to engage with questions about power or make 
recommendations that would challenge the ways dominant 
neoliberalism restricts health governance options.17 
Yamin et al write, health has been “depoliticized by the 
disciplinary orthodoxies of medicine and public health.”18 
The dominant culture of positivistic scientific inquiry, drawn 
from the medical field, guides the study of health policy and 
governance.19 Within this orthodoxy ill health is not only 
predominately defined as an individual biological problem 
with a technical solution, but public health scholarship is 
dominated by empirical analysis of observable patterns, 
cause and effect.20 For example, Gill and Benatar argue the 
Consortium of Universities for Global Health is “steeped 
in the biomedical model of disease.”3 While suitable for 
medical research, this model cannot interrogate the political 
ideologies and power structures that shape health policy-
making, or identify how they have evolved from legacies of 
imperialism and colonialism.17 This contradiction – between 
the positivistic ideals of public health research and the need for 
critical analysis of health policy and governance – discourages 
research on the political determinants of health.
Which in turn serves neoliberal interests. Kay and Williams 
write of an “enduring ideational alliance of neoliberalism and 
the biomedical model,” which melds medical discourse with 
the interests of global capital.15 This alliance not only defines 
ill health as primarily an issue of resources requiring technical 
and market-based solutions, it delegitimatizes analysis that 
asks critical questions about health policy and governance.21 
For, as Bambra et al write, the depoliticization of health “does 
not occur by chance: both the masking of the political nature 
of health, and the forms of the social structures and processes 
that create, maintain and undermine health, are determined 
by the individuals and groups that wield the greatest political 
power.”19 In other words, the depoliticization of health serves 
powerful interests by delegitimizing analysis that might reveal 
and question those interests.
Despite shying away from political analysis, Lencucha and 
Throw’s Perspective does call for critical interrogation of 
the structures of neoliberalism. They advocate “systematic 
engagement with the assumptions that continue to structure 
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institutions across sectors.”2 The process of identifying 
and interrogating assumptions facilitates awareness of the 
constraints actors operate within, which in turn enables 
opportunities to challenge these, expose contradictions (for 
example, by raising questions about why commercial actors 
often have input into health policies, but health actors rarely 
have input into commercial policies), and pose alternatives 
(such as allowing health actors equal input into commercial 
policies). The next step is then to generate alternatives. For 
example, Benatar et al propose what they term “development 
of sustainability” as an ethical framework and political 
ideology based on human rights, social democracy and social 
justice.22
Mackenbach rephrases the quote from Virchow noted at the 
start as, “human health and disease are the embodiment of the 
successes and failures of society as a whole, and the only way 
to improve health and reduce disease is by changing society 
by, therefore, political action.”1 If, as Lencucha and Throw 
convincingly illustrate, neoliberalism is THE structural 
barrier to NCDs prevention, then health scholars need to 
not only describe the limits it imposes, but also challenge 
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